进,指国际著名投资银行美国高盛集团低调地介入国内药品零售市场。 退,指药品零售领域的“先锋”——深圳海王星辰的董事长兼总经理朱丹默默地辞职。 从某种意义上说,是高盛的“进”直接点燃了朱丹“退”的导火索:6月28日,高盛与海王星辰悄然签订投资协议;9月初,市场上即传出朱丹行将去职的风声;今日,此消息已得到确证——9月底,在与一手组建起来的团队进行最后告别后,刚入不惑之年的朱丹即远赴国外休假。 Jin, refers to the internationally renowned investment bank Goldman Sachs Group low-profile intervention in the domestic pharmaceutical retail market. Back, refers to the field of drug retail “pioneer” - Shenzhen Neptune’s chairman and general manager Zhu Dan quietly resigned. In a sense, it is Goldman Sachs “Jin” directly ignited Zhu Dan “retreat” of the fuse: June 28, Goldman Sachs and Nepstar quietly signed an investment agreement; in early September, the market that Zhu Dan will step down The news today has been confirmed - at the end of September, after a final farewell with the team that was first-hand set up, Zhu Dan, who had just started his own career, traveled abroad for a vacation.